• PVX Protein Platforms for RNA Delivery

  2026-10-06

  A 2025 Scientific Reports study examined potato virus X coat-protein assemblies as a conceptual delivery platform for mRNA and circular RNA. The reported results support feasibility in cell-based reporter experiments, but the evidence remains early-stage: it does not establish clinical efficacy, tissue targeting, comparative performance against lipid nanoparticles, or the suitability of any particular commercial mRNA product.

• O-propargyl-puromycin and B-Cell Translation

  2026-10-06

  O-propargyl-puromycin (OPP) provides a mechanistically informative view of nascent protein production, helping translational researchers connect mitochondrial state, global translation, and antibody output in B cells. Building on a 2026 Science Advances study of Pcbp1, this article explains how OPP can complement mitochondrial, immunophenotypic, and proteomic evidence while clarifying what the assay can—and cannot—establish.

• TEV Protease and Cas13d: Evidence and Limits

  2026-10-05

  A source-grounded overview of how Tobacco Etch Virus protease is understood as a recombinant protein tag-removal enzyme, how that principle relates to engineered Cas13d research, and what the available evidence does—and does not—establish.

• PGF2α/PTGFR–HIF-1α in Endometrial Breakdown

  2026-10-05

  A 2024 mouse menstrual-like model study identifies PGF2α/PTGFR as a functional mediator of endometrial breakdown and vascular permeability downstream of HIF-1α. By combining pharmacological inhibition, vascular readouts, histology, and promoter-binding analysis, the work provides a mechanistic framework for interpreting prostaglandin-controlled tissue shedding while highlighting important limits to human translation.

• ML385 and the Logic of NRF2–Ferroptosis Evidence

  2026-10-04

  ML385 is a selective NRF2 inhibitor that can help researchers test whether antioxidant signaling contributes to ferroptosis and therapeutic resistance. This evidence-focused guide connects NSCLC research with a mouse study of diabetic cognitive decline while clarifying what the findings do—and do not—demonstrate.

• A23187, Free Acid: From Calcium Flux to Cell Fate

  2026-10-03

  A mechanistic and translational framework for using A23187, free acid as a calcium ionophore while distinguishing calcium-driven signaling, growth inhibition, and true cell killing.

• Pravastatin sodium Assay Workflows

  2026-10-02

  Use Pravastatin sodium as a mechanistic HMG-CoA reductase inhibitor to connect cholesterol biosynthesis inhibition with LDL handling, hepatocyte safety, and transporter-aware botanical screening. The workflow combines dose planning, orthogonal readouts, and troubleshooting strategies that help distinguish target engagement from nonspecific cytotoxicity.

• Standardized Whole-Blood Stimulation in Immunometabolism

  2026-10-01

  Zhao and colleagues present a standardized whole-blood stimulation protocol for testing how metabolic interventions reshape immune-cell cytokine production. By combining defined immune stimuli with pathway-directed metabolic inhibitors, the workflow improves comparability across donor studies while retaining the cellular interactions present in whole blood.

• AP20187 for Reproducible Cell Signaling Assays

  2026-10-01

  This scenario-driven guide explains how AP20187, SKU B1274, can support controlled fusion-protein signaling in viability, proliferation, and cytotoxicity workflows. It separates evidence-backed product properties from assay-specific optimization and provides practical guidance for stock preparation, controls, interpretation, and vendor selection.

• NMDA (N-Methyl-D-aspartic acid) in Cell Assays

  2026-09-30

  Learn how NMDA (N-Methyl-D-aspartic acid), SKU B1624, supports controlled excitotoxicity research, calcium influx measurement, and oxidative stress assay design. This scenario-based guide connects reagent handling with evidence from a 2025 glaucoma model while emphasizing appropriate controls and interpretation.

• Resiniferatoxin and TRPV1-Positive Afferent Silencing

  2026-09-30

  Szallasi’s 2023 review explains how Resiniferatoxin (RTX) converts exceptionally strong TRPV1 activation into selective, prolonged silencing of TRPV1-positive sensory afferents. The evidence supports route-specific investigation in bladder dysfunction, osteoarthritis, cancer pain, neurogenic inflammation, and other localized pain settings, while also emphasizing important translational and safety limitations.

• TAK-242 (Resatorvid): TLR4 Assay Guide

  2026-09-29

  A practical, scenario-based guide to using TAK-242 (Resatorvid), a selective TLR4 inhibitor, in viability, proliferation, and inflammatory-response assays. It explains how SKU A3850 can support controlled TLR4 signaling experiments through appropriate dosing, vehicle controls, stock handling, and interpretation of LPS-induced effects.

• Baricitinib (LY3009104) for JAK1/2 Assays

  2026-09-29

  Baricitinib (LY3009104) provides a selective pharmacological way to interrogate JAK1/2-dependent cytokine signaling without treating PD-L1 and IL-6 association as the same mechanism. This practical guide connects spatial proteomics findings in primary sclerosing cholangitis with dose-response, phospho-STAT3, viability, and translational assay workflows.

• Ampicillin sodium: Assay Workflows & Troubleshooting

  2026-09-28

  Build more reproducible antibacterial activity assays with Ampicillin sodium by combining mechanism-led concentration design, resistance-aware strain panels, and disciplined solution handling. The workflow also shows how in vitro MIC data can inform—but not replace—carefully controlled bacterial infection model studies.

• Dihydrotestosterone: Context-Driven Assay Design

  2026-09-28

  Dihydrotestosterone (DHT) can produce different biological readouts across androgen-responsive tissues. This article connects bladder-cancer and muscle-model evidence to practical assay design, while clarifying what a mouse spermatogonial stem-cell study does—and does not—show about DHT.

8476 records 2/566 page Previous Next 12345 下5页 Last page